EGFR and ovarian carcinoma: Moreover, the most comprehensive profiles characterized thus far have focused on gene alterations, via comparative genomic hybridization or gene microarrays (reviewed in [168, 169]), which provide an incomplete profile of ovarian cancer cells, particularly in the case of protein signaling-dependent alterations such as EGFR activation.